Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue
Abstract
Introduction: Hepatitis C virus (HCV) infection is a worldwide problem and hepatitis, which is its natural unfavourable course, is still a challenge for hepatologist. At present, standards of treatment are changing from combined therapy with interferon alpha (IFN-α) and ribavirin to new antiviral drugs. The current classification divides interferon induced thyroid diseases (IITD) into two groups: autoimmune (Hashimoto disease, Graves disease, positive antithyroid autoantibodies in euthyroid patients) and non-autoimmune (destructive thyroiditis, non-autoimmune hypothyroidism). A common complication of cytokine therapy is the induction of antithyroid autoantibodies de novo without thyroid dysfunction. During therapeutic regimens combined with ribavirin, destructive thyroiditis with typical biphasic course is more common than in IFN-α monotherapy. Clinically, overt pathologies often have discrete symptoms, which cause diagnostic and therapeutic dilemmas. Aims: The aim of this study was to estimate IITD occurrence, to find risk factors for IITD development. Material and methods: The study group consisted of 66 patients treated for HCV infection. Before and during antiviral therapy, hormonal (TSH, fT4, fT3), immunological (thyroid autoantibodies), ultrasonographic and genetic (HLA-A2) parameters were evaluated. Results: Hormonal disturbances were detected in 24.2% of patients; however, 43.9% of patients had positive thyroid autoantibodies (de novo) without hormonal imbalance. Multivariate analysis revealed the following: female sex, elevated TSH level, occurrence of anti-TPO autoantibodies (TPO-Ab), and increased blood velocity in thyroid arteries are risk factors for IITD development. In conclusion: Thyroid disorders are common during IFN-α therapy. Previous epidemiological data seem to be underestimated. Important risk factors for IITD development are: female sex, elevated serum TSH concentration (≥2.5 μU/mL), positive TPO-Ab and increased blood velocity in thyroid arteries.
Authors and Affiliations
Łukasz Obołończyk, Małgorzata Siekierska-Hellmann, Piotr Wiśniewski, Anna Lewczuk, Monika Berendt-Obołończyk, Zofia Michalska, Danuta Radowska, Grażyna Moszkowska, Agnieszka Bianek-Bodzak, Krzysztof Sworczak
Keywords
Related Articles
- EP ID EP223268
- DOI 10.5604/01.3001.0010.4782
- Views 174
- Downloads 0
Cancer chemoprevention – selected molecular mechanisms
The effect of diet on cancer formation and prevention of carcinogenesis has attracted considerable attention for years and is the subject of several studies. Some components of the daily diet, such as resveratrol, curcum...
Aflatoksyny – charakterystyka i wpływ na zdrowie człowieka
W środowisku naturalnym powszechnie występują grzyby pleśniowe, których produktem wtórnego metabolizmu są mykotoksyny. Aspergillus flavus oraz A. parasiticus są gatunkami grzyba pleśniowego odpowiedzialnego za wytwarzani...
Research on new drugs in the therapy of bladder cancer (BC)
New, more effective and safer therapies in bladder cancer are being developed. Most attention is focused on monoclonal antibody therapies, targeted therapies and immunotherapy. Numerous pre-clinical and clinical studies...
Molekularne aspekty działania 17β-estradiolu i progesteronu w komórkowych szlakach sygnałowych
17β-estradiol i progesteron, steroidy płciowe omawiane zazwyczaj w związku z modulacją funkcji reprodukcyjnych, regulują wiele wewnątrzkomórkowych procesów w komórkach docelowych, wyposażonych w odpowiednie receptory. Os...
The role of gastric mucins in interactions with Helicobacter pylori
Helicobacter pylori is a Gram-negative bacterium which colonizes the stomach of over 50% of the world’s population. The pathogen is responsible for many diseases including gastritis, ulcers and also gastric cancers. It i...